GeneDx alternatives and competitors
The closest alternatives to GeneDx are SOPHiA GENETICS, Helix, Invitae and Ambry Genetics.
Rare disease genomic diagnosis company (NASDAQ: WGS) in Gaithersburg, Maryland, running exome and genome sequencing in its own accredited laboratory and interpreting it with automation, machine learning and clinical scientists over GeneDx Infinity, its dataset of prior cases.
10 alternatives to GeneDx
What each product does, with its price as the vendor publishes it.
-
S
Cloud genomics analysis company (NASDAQ: SOPH) based in Rolle, Switzerland and Boston.
Price: No published price
-
H
Genomics company in San Mateo, California, sequencing with its proprietary Exome+ assay in a CLIA certified, CAP accredited laboratory.
Price: No published price
-
I
Invitae is a genetic testing brand owned by Labcorp, which acquired the business in 2024 after Invitae's bankruptcy. It keeps its own site and test menu and now presents itself as Invitae and Labcorp together, with some billing handled by Labcorp Genetics.
Price: No published price
-
A
Ambry Genetics is a genetic testing laboratory in Aliso Viejo, California, founded in 1999 and owned since 2025 by Tempus AI.
-
M
Myriad Genetics is a genetic testing company in Salt Lake City, Utah, listed on NASDAQ as MYGN, that runs its tests in its own accredited laboratories.
Price: Most eligible patients pay $0; financial assistance tiers of $0, $100 or $249
-
M
MyOme is a genomics company in Menlo Park, California, with a CLIA certified and CAP accredited laboratory, that sells whole genome screening built around integrated risk scores.
Price: No published price
-
C
Caris Life Sciences (NASDAQ: CAI) is a precision oncology company in Irving, Texas. It profiles tumors in its own laboratories by whole exome and whole transcriptome sequencing and layers AI signatures on the results.
Price: No published price
-
V
Veracyte sells genomic tests that pair a laboratory expression assay with a learned classifier, used by urologists, oncologists and endocrinologists to decide how intensively to treat a cancer or whether a thyroid nodule needs surgery.
Price: No published price
-
G
Multi cancer early detection company (NASDAQ: GRAL). The Galleri test uses targeted methylation sequencing of cell free DNA from a blood draw, with machine learning classifiers that detect a cancer signal and predict its origin, across more than 50 cancer types.
Price: $949 per test (list price)
-
4
Precision oncology company running hospital linked genomics laboratories in India, the United Arab Emirates, Nepal and the Philippines.
Price: No published price
More GeneDx comparisons
Side by side comparisons of GeneDx with products not listed above.
GeneDx alternatives, answered
What are the best alternatives to GeneDx?
The closest alternatives to GeneDx are SOPHiA GENETICS, Helix, Invitae, Ambry Genetics and Myriad Genetics. Invitae is a genetic testing brand owned by Labcorp, which acquired the business in 2024 after Invitae's bankruptcy. Ambry Genetics is a genetic testing laboratory in Aliso Viejo, California, founded in 1999 and owned since 2025 by Tempus AI. Myriad Genetics is a genetic testing company in Salt Lake City, Utah, listed on NASDAQ as MYGN, that runs its tests in its own accredited laboratories.
Who are GeneDx's competitors?
GeneDx's competitors in the Diagnostics & Genomics category include SOPHiA GENETICS, Helix, Invitae, Ambry Genetics, Myriad Genetics and MyOme.